South Korea · Delayed Price · Currency is KRW KUKJEON PHARMACEUTICAL Statistics
Total Valuation
KOSDAQ:307750 has a market cap or net worth of KRW 199.54 billion. The enterprise value is 214.45 billion.
| Market Cap | 199.54B |
| Enterprise Value | 214.45B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:307750 has 53.71 million shares outstanding. The number of shares has increased by 0.77% in one year.
| Current Share Class | 53.71M |
| Shares Outstanding | 53.71M |
| Shares Change (YoY) | +0.77% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 52.50% |
| Owned by Institutions (%) | 0.13% |
| Float | 25.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.52 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | 26.63 |
| P/OCF Ratio | 18.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 82.82, with an EV/FCF ratio of 28.62.
| EV / Earnings | -49.88 |
| EV / Sales | 1.64 |
| EV / EBITDA | 82.82 |
| EV / EBIT | n/a |
| EV / FCF | 28.62 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.13 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 17.23 |
| Debt / FCF | 6.13 |
| Interest Coverage | -0.50 |
Financial Efficiency
Return on equity (ROE) is -4.99% and return on invested capital (ROIC) is -2.22%.
| Return on Equity (ROE) | -4.99% |
| Return on Assets (ROA) | -0.82% |
| Return on Invested Capital (ROIC) | -2.22% |
| Return on Capital Employed (ROCE) | -2.27% |
| Weighted Average Cost of Capital (WACC) | 2.39% |
| Revenue Per Employee | 736.18M |
| Profits Per Employee | -24.15M |
| Employee Count | 178 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 5.02 |
Taxes
| Income Tax | -844.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.44% in the last 52 weeks. The beta is -0.61, so KOSDAQ:307750's price volatility has been lower than the market average.
| Beta (5Y) | -0.61 |
| 52-Week Price Change | +29.44% |
| 50-Day Moving Average | 3,878.40 |
| 200-Day Moving Average | 3,761.65 |
| Relative Strength Index (RSI) | 42.03 |
| Average Volume (20 Days) | 2,929,930 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:307750 had revenue of KRW 131.04 billion and -4.30 billion in losses. Loss per share was -86.00.
| Revenue | 131.04B |
| Gross Profit | 18.47B |
| Operating Income | -2.56B |
| Pretax Income | -5.66B |
| Net Income | -4.30B |
| EBITDA | 2.66B |
| EBIT | -2.56B |
| Loss Per Share | -86.00 |
Balance Sheet
The company has 30.55 billion in cash and 45.90 billion in debt, with a net cash position of -15.35 billion or -285.86 per share.
| Cash & Cash Equivalents | 30.55B |
| Total Debt | 45.90B |
| Net Cash | -15.35B |
| Net Cash Per Share | -285.86 |
| Equity (Book Value) | 95.87B |
| Book Value Per Share | 1,900.32 |
| Working Capital | 8.67B |
Cash Flow
In the last 12 months, operating cash flow was 10.61 billion and capital expenditures -3.11 billion, giving a free cash flow of 7.49 billion.
| Operating Cash Flow | 10.61B |
| Capital Expenditures | -3.11B |
| Depreciation & Amortization | 5.23B |
| Net Borrowing | -27.35B |
| Free Cash Flow | 7.49B |
| FCF Per Share | 139.53 |
Margins
Gross margin is 14.09%, with operating and profit margins of -1.96% and -3.28%.
| Gross Margin | 14.09% |
| Operating Margin | -1.96% |
| Pretax Margin | -4.32% |
| Profit Margin | -3.28% |
| EBITDA Margin | 2.03% |
| EBIT Margin | -1.96% |
| FCF Margin | 5.72% |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.77% |
| Shareholder Yield | -0.50% |
| Earnings Yield | -2.15% |
| FCF Yield | 3.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:307750 has an Altman Z-Score of 2.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 4 |